Answers are grounded in this paper and cite their sources.
Infective endocarditis (IE) has been a relatively rare entity in children, but its incidence seems to be increasing over the years. This is not surprising, as it is inevitably the downside of advancing therapeutic technologies including various invasive procedures leading to prolonged hospitalization in intensive care units. Further, with abatement in the incidence of rheumatic heart disease, IE in children is now predominantly being reported in congenital heart disease, either affecting the native abnormal valves or surgically repaired valves, implanted vascular grafts, or prosthetic cardiac valves.[1] The Duke criteria proposed in 1994, modified in 2000, defined "typical" microorganisms for IE as viridans streptococci, Streptococcus bovis, HACEK group, community-acquired Staphylococcus aureus or enterococci.[1] Microorganisms other than the above-mentioned ones, have also been found to cause IE, though less frequently. They have been together termed broadly as "miscellaneous" and have largely been ignored. However, there has been growing evidence of "unusual" pathogens with a definite change in the epidemiological pattern of IE globally. Although adults constitute majority of such reports of IE, unusual pathogens are also emerging in pediatric reports. Further, around 10% of cases of IE had hitherto been labeled as "blood culture-negative endocarditis (BCNE)" when conventional blood cultures failed to identify a causative pathogen, attributed to either prior use of antibiotics or to "atypical" microorganisms which were slow-growing or requiring special media. In many such BCNE, organisms such as Bartonella sp., Legionella pneumophila, Abiotrophia, and fungi have been identified by polymerase chain reaction and sequencing. In view of such changing trends in IE over the last two decades, the International Society for Cardiovascular Infectious Diseases updated the diagnostic criteria for IE in 2023,[2] expanding the list of "typical microorganisms," both for native and for prosthetic valves. This issue of Indian Pediatrics Case Reports publishes three isolated reports of IE due to unconventional organisms, each case being unique: one of the reports by Manugu et al.[3] describes tricuspid valve endocarditis by Streptococcus sinensis in an 8-year-old child, with perimembranous ventricular septal defect (VSD), in the absence of conventionally known risk factors. The second report by Ayoub TU et al.[4] describes a 13-year-old child with IE due to Pasteurella multocida affecting a homograft conduit surgically created during prior VSD repair. The third report by Patra S et al.[5] was a case of polymicrobial IE, due to Candida tropicalis and Serratia marcescens, involving a tricuspid valve, in a neonate with umbilical catheterization. While the two older children with IE recovered with treatment, the neonate succumbed to complications of IE. This issue of the journal thus highlights the growing evidence of IE in children caused by unusual organisms in the current era of advancing medical technologies. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.
No takes yet. Share an insight, caveat, or question.
Kirtisudha Mishra (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: